Pharmacy owners across the East & North Midlands and the North West are invited to meet the Community Pharmacy England team to discuss the issues that matter to you. Chief Executive Janet Morrison and the team are heading to Nottingham on Tuesday 9th July and then onto Haydock on Wednesday 10th July to talk directly to
Read moreClass 4 Medicines Defect Information: Grepid 75 mg film coated tablets (Kent Pharma Livery) Drug alert number: EL (24)A/24 Date issued: 24 June 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Grepid 75 mg film coated tablets (Kent Pharma Livery) Company name: PHARMATHEN S.A. Product name:
Read moreDepartment of Health and Social Care (DHSC) has issued a medicine supply notification for Disopyramide (Rythmodan Retard®) 250mg modified-release tablets and disopyramide (Rythmodan®) 100mg capsules. MSN/2024/075 Tier 2 – medium impact Date of issue: 5th June 2024 Disopyramide (Rythmodan Retard®) 250mg modified-release tablets are out of stock until mid-July 2024. Disopyramide (Rythmodan®) 100mg capsules will
Read morePharmacy owners and their teams are being asked to tell us about the informal advice they provide and the impact Pharmacy First is having through the Pharmacy Advice Audit (which closes on Friday 28th June). Years of financial and operational pressures are continuing to take their toll on the sector, and in this short video
Read moreCommunity Pharmacy England previously published new guidance to help community pharmacy owners complete the latest Data Security and Protection Toolkit. The Toolkit is used to make a pharmacy’s information governance (IG) declaration and must be completed by Sunday 30th June 2024. Around three quarters of pharmacies have now completed their Toolkit ahead of the nearby
Read moreA new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 17 Issue 11 June 2024) has been published and includes articles on: Topiramate (Topamax®): introduction of new safety measures, including a Pregnancy Prevention Programme Warfarin: be alert to the risk of drug interactions with tramadol Letters and medicine recalls sent to healthcare
Read moreDepartment of Health and Social Care (DHSC) has issued a medicine supply notification for Flixotide® (fluticasone) 125micrograms/dose and 250micrograms/dose Evohaler® MSN/2024/074 Tier 2 – medium impact Date of issue: 19th June 2024 Flixotide® (fluticasone) 125micrograms/dose and 250micrograms/dose Evohaler® is out of stock from late June until mid-July 2024. Flixotide® (fluticasone) Accuhaler® 100microgram, 250microgram and
Read moreNHS England have announced that from 18th June 2024, clinical IT system suppliers will commence the roll out of a new feature enabling Pharmacy First referrals from general practices using EMIS Web Local Services or PharmRefer to flow into the workflows in pharmacy clinical systems. Referrals will be received into the same IT system workflow
Read moreDepartment of Health and Social Care (DHSC) has issued a medicine supply notification for Triamcinolone acetonide suspension for injection vials (Kenalog® 40mg/1ml and Adcortyl® 50mg/5ml) MSN/2024/073 Tier 2 – medium impact Date of issue: 18th June 2024 Triamcinolone acetonide suspension for injection vials (Kenalog® 40mg/1ml and Adcortyl® 50mg/5ml) are out of stock until w/c 24th
Read moreTO NOTE: This MSN is the one of two covering supply issues with insulin vials. MSN/2024/057 issued on 20/05/24 covered Humulin® S (insulin soluble human). This MSN (MSN/2024/072) covers Humalog® (insulin lispro). CAUTION: These products have similar sounding names and appropriate risk minimisation strategies should be implemented to ensure actions are carried out for specific
Read more
